Ramy Sedhom: Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability

Ramy Sedhom, Medical Oncologist and Director of Palliative Medicine at Penn Medicine, shared a post on X/Twitter:

”This work needs more attention! Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability.

Mentee of Supriya Mohile shows primary dose reduction improves treatment tolerability among older adults with advanced cancer and age-related conditions.”

Read further.
Source: Ramy Sedhom/X